Latest news with #BestPractices
Cision Canada
4 days ago
- Business
- Cision Canada
Frost & Sullivan Names Dassault Systèmes as Recipient of Its 2025 Global Transformational Innovation Leadership Award for Excellence in Smart Manufacturing Life Sciences Solutions
Recognized for its leadership in driving digital transformation and sustainable innovation through virtual twin technology in the life sciences manufacturing sector. SAN ANTONIO, June 18, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Dassault Systèmes has been awarded the 2025 Global Transformational Innovation Leadership Award in the smart manufacturing life sciences solutions industry for its outstanding achievements in digital innovation, strategic execution, and customer-centric transformation. This recognition highlights Dassault Systèmes' consistent leadership in driving measurable outcomes, strengthening its market position, and delivering scalable solutions that enable life sciences companies to thrive in an increasingly complex and regulated environment. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Dassault Systèmes excelled in both, demonstrating its ability to align strategic initiatives with emerging market demand while executing with efficiency, adaptability, and scale. The company's 3DEXPERIENCE platform supports end-to-end digital transformation across research, clinical development, engineering, manufacturing, and supply chain functions. "Dassault Systèmes empowers clients in the life sciences space to prioritize digital transformation initiatives, achieve rapid operational wins, and sustain long-term innovation. Through the intelligent use of virtual twin technology and generative AI, the company boosts efficiency, fosters innovation, and champions sustainability," said Ojaswi Rana, Best Practices Research Analyst at Frost & Sullivan. "The 3D EXPERIENCE platform revolutionizes manufacturing by providing a unified environment that integrates and optimizes the entire production process. Utilizing virtual twin technology and advanced data analytics, it enhances operational efficiency, reduces costs, and fosters seamless collaboration among manufacturing teams. The platform drives sustainable manufacturing practices, optimizes supply chains, and supports continuous process improvements, ensuring top-tier manufacturing performance and product quality." said Claire Biot, Vice President Life Sciences and Healthcare at Dassault Systèmes . Each year, Frost & Sullivan presents the Transformational Innovation Leadership Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. Contact us: Start the discussion. Contact:
Yahoo
20-05-2025
- General
- Yahoo
Olney Police Department celebrates new building with ribbon cutting
OLNEY, TX (KFDX/KJTL) — On Monday, May 19, the Olney Police Department was out with the old and in with the new. The department held a ribbon-cutting to showcase its new state-of-the-art building. 'The facility was extremely worn down, tired [and] failing,' Olney Police Chief Dan Birbeck said. 'So we were really honored to be able to get out of that and into a new, fresh environment.' Birbeck said the new project was about five years in the making. It allowed the department to improve its technology and the way its officers handle cases. 'In addition to a lot of upgrades, one of those was a new interview room that we now have, that we didn't have at the old facility. We have a new IT infrastructure where everything has got redundant systems to it, so we don't have to worry about it,' Birbeck said. 'We have an upgraded property and evidence system in storage. So, we meet best practices which was another goal of ours to be able to obtain Texas Police Chief Association Best Practices.' Birbeck said obtaining that accreditation from the TPCA would not have been possible without generous donors and community members. During the ceremony, the building was named after Miss Perry, a long-time contributor to the Olney community. It is located at 210 South Grand Avenue, so anyone can stop by and see it. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
07-02-2025
- Business
- Yahoo
GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan
- GCCL's "One-Stop Lab Solution" sets the industry benchmark with unmatched competitiveness and a dedication to global excellence. - Continuing its growth as a globally recognized leader in clinical sample analysis, driven by customer-centric values. YONGIN, South Korea, Feb. 7, 2025 /PRNewswire/ -- GCCL(Global Clinical Central Lab), a leading Korean clinical trial sample analysis company, reinforced its position in the global market by receiving Frost & Sullivan's 2025 Best Practices Customer Value Leadership Award in the Asia-Pacific clinical sample analysis services industry. Frost & Sullivan, a global-established growth consulting company, honors companies that demonstrate exceptional leadership, innovation, and performance through its annual Best Practices awards. The organizations excel in delivering outstanding value by assessing the market participants' value. Using a rigorous evaluation process, Frost & Sullivan assesses criteria including growth potential, customer acquisition, customer experience, operational efficiency, and equity. Having excelled in these areas, GCCL earned this recognition for its comprehensive services, customer-centric approach, and technological leadership. GCCL is one of the few clinical trial sample analysis service providers offering a "one-stop lab solution" that integrates central lab, bioanalysis lab, and BSL-3[i] lab services into a single, unified system. This consolidated approach minimizes sample movement between facilities, reducing logistics time and costs while ensuring sample stability. As a result, it enhances data reliability and strengthens the credibility of study outcomes. By leveraging cutting-edge analytical platforms and implementing its Lab Information Management System (LIMS), GCCL maintains high standards in global clinical research. With tailored solutions, GCCL delivers precision and efficiency in clinical trials, solidifying its position as a trusted partner in new drug development. Frost & Sullivan highlighted GCCL's integrated lab service model, highlighted that systematic quality control and industry-leading technological innovation were as key factors in earning the award. This recognition underscores GCCL's leadership in the APAC region, showcasing its position as APAC's and unmatched capabilities in clinical sample analysis. Kwan-goo Cho, CEO of GCCL, stated, "The award is a global recognition of our efforts and achievements in prioritizing customer value and proof that GCCL has established itself as the solid leader in the market." He added, "We will continue to drive technological innovation and improve service quality to meet the rising demand in global clinical trials and to lead in the role as a trusted partner for new drug development." GCCL is a Good Clinical Laboratory Practice (GCLP)-certified lab accredited by the Ministry of Food and Drug Safety of South Korea. The company provides clinical trial sample analysis services globally across all clinical trial phases(I-IV), leveraging advanced analytical platforms including ddPCR technology, and its specialized expertise in sample analysis and method development. Serving pharmaceutical and biotechnology companies as well as in Korea, Asia, and beyond, GCCL is committed to deliver world-class, customized clinical trial solutions. [i] Bio safety Level 3 Contact: Sandra Woohywoo@ Harry Honghonghr@ View original content to download multimedia: SOURCE GCCL Sign in to access your portfolio
